Yakup Duzkopru

Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?

M. Uysal, M. Kaplan, M. Ozkan, 2015, Clinical genitourinary cancer.

Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?

M. Uysal, M. Kaplan, M. Ozkan, 2015, Journal of chemotherapy.

Second-line Chemotherapy in Advanced Gastric Cancer: Taxanes versus 5-FU-Based Treatment.

G. Imamoglu, T. Eren, O. Dogan, 2023, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.